The Mammotome Prima™ MR system streamlines workflow with an intuitive in-room design¹. Clinicians benefit from larger tissue samples² enabled by stronger vacuum³ and an 8-gauge needle. This is made possible by 75% less tubing compared to other systems⁴. Less tubing also results in faster setup and cleanup and less biohazard waste. Additional highlights include convenient aperture size and vacuum strength adjustments on a touchscreen interface.

Ultimately, these combined benefits ensure clinicians can focus on delivering safe, accurate, and compassionate care, translating into a better experience for patients. "Our commitment to advancing breast care drives every innovation we bring to market," said Scott Treml, Mammotome Vice President and General Manager. "As the first of its kind in-room solution, the Mammotome Prima™ MR system empowers clinicians with greater efficiency and confidence, ultimately improving the patient experience."

The Mammotome Prima™ MR system has secured CE mark, and first cases are underway in select European countries. The system will be making its debut at the European Society of Radiology (ECR) Congress in March. Mammotome will be expanding access in select global markets throughout 2026.